Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


F.D.A. Panel Splits on Whether to Approve New Diabetes Drug

External Link - Source: The New York Times

An advisory panel for the Food and Drug Administration split evenly on Thursday over whether the agency should approve the first oral medication to treat Type 1 diabetes.

The committee voted 8-8, leaving it up to the agency to decide by the end of March whether the drug, sotagliflozin, should reach the market.

This entry was posted in Ethics, Media, Pharmaceuticals and tagged . Bookmark the permalink.